GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandion Oncology A/S (OSTO:SCOL) » Definitions » FCF Yield %

Scandion Oncology A/S (OSTO:SCOL) FCF Yield % : -101.42 (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Scandion Oncology A/S FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Scandion Oncology A/S's Trailing 12-Month Free Cash Flow is kr-66.44 Mil, and Market Cap is kr65.51 Mil. Therefore, Scandion Oncology A/S's FCF Yield % for today is -101.42%.

The historical rank and industry rank for Scandion Oncology A/S's FCF Yield % or its related term are showing as below:

OSTO:SCOL' s FCF Yield % Range Over the Past 10 Years
Min: -245.81   Med: 0   Max: 0
Current: -101.42


OSTO:SCOL's FCF Yield % is ranked worse than
85.52% of 1554 companies
in the Biotechnology industry
Industry Median: -14.135 vs OSTO:SCOL: -101.42

Scandion Oncology A/S's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.


Scandion Oncology A/S FCF Yield % Historical Data

The historical data trend for Scandion Oncology A/S's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandion Oncology A/S FCF Yield % Chart

Scandion Oncology A/S Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial -6.98 -3.70 -17.40 -90.57 -46.76

Scandion Oncology A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -119.46 -174.80 -95.24 -36.64 -56.82

Competitive Comparison of Scandion Oncology A/S's FCF Yield %

For the Biotechnology subindustry, Scandion Oncology A/S's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scandion Oncology A/S's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scandion Oncology A/S's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Scandion Oncology A/S's FCF Yield % falls into.



Scandion Oncology A/S FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Scandion Oncology A/S's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-76.042 / 162.62426194
=-46.76%

Scandion Oncology A/S's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-14.513 * 4 / 102.174093616
=-56.82%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scandion Oncology A/S FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Scandion Oncology A/S FCF Yield % Related Terms

Thank you for viewing the detailed overview of Scandion Oncology A/S's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Scandion Oncology A/S (OSTO:SCOL) Business Description

Traded in Other Exchanges
Address
Fruebjergvej 3, Symbion, Copenhagen, DNK, 2100
Scandion Oncology A/S is a clinical-stage biotechnology company developing first-in-class medicines aimed at treating cancer that is resistant to current treatment options. Cancer Drug Resistance Company discovers and develops first-in-class medicines aimed at treating cancer that is resistant to current treatment options.

Scandion Oncology A/S (OSTO:SCOL) Headlines

No Headlines